Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Indocyanine green

A trained physician will inject 0.1 ml of the ICG in to the web spaces of the hands in both upper extremities.

DEVICE

MultiSpectral Imaging System

Once the ICG is injected, the contrast is expected to fluoresce underneath the MultiSpectral Imaging System. Multispectral video and still images will be recorded at the study visits.

Trial Locations (1)

14642

RECRUITING

University of Rochester, Rochester

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Rochester

OTHER